| Structure | Chemical Name | CAS | MF |
|
(R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid
|
1422514-05-3
|
C22H26FN3O6S
|
|
((3S,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl sulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate)calcium (II)
|
1422515-55-6
|
C22H30CaFN3O6S
|
|
T-3775440 hydrochloride
|
1422535-52-1
|
C18H23ClN4O
|
|
Propargyl-PEG4-5-nitrophenyl carbonate
|
1422540-81-5
|
C18H23NO9
|
|
S-acetyl-PEG4-Propargyl
|
1422540-88-2
|
C13H22O5S
|
|
Azido-PEG4-4-nitrophenyl carbonate
|
1422540-98-4
|
C15H20N4O8
|
|
(Z)-2-Fluoro-N'-hydroxybenzimidamide
|
1422554-22-0
|
C7H7FN2O
|
|
BET-IN-1
|
1422554-34-4
|
C25H30N4O4
|
|
Rosuvastatin IMpurity SodiuM Salt (5-Oxo Rosuvastatin SodiuM Salt)
|
1422619-13-3
|
C22H26FN3O6S
|
|
Sodium 1,1-difluoroethylsulfinate
|
1422738-67-7
|
C2H3F2NaO2S
|
|
2-bromo-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid
|
1422772-78-8
|
C7H4BrN3O2
|
|
Methyl 2-bromo-5H-pyrrolo[2,3-b]pyrazine-7-carboxylate
|
1422772-79-9
|
C8H6BrN3O2
|
|
1-Iodoimidazo[1,5-a]pyridine
|
1422773-18-9
|
C7H5IN2
|
|
Trans-4-Phenyl-1-(Pyridin-2-Ylmethyl)Pyrrolidine-3-Carboxylic Acid
|
1422948-25-1
|
C17H18N2O2
|
|
(3R,5R)-Rosuvastatin Lactone
|
1422954-11-7
|
C22H26FN3O5S
|
|
NZWJKTHFNLHUJO-NWZSJJIMSA-N
|
1422954-12-8
|
C22H26FN3O5S
|
|
Rosuvastatin Impurity 14
|
1422954-13-9
|
C22H26FN3O5S
|
|
2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro-
|
1422955-31-4
|
C12H6ClFN4O3
|
|
2-Benzofurancarboxylic acid, 5-(1-piperazinyl)-, ethyl ester, (Hydrochloride), hydrate (1:2:1)
|
1422956-31-7
|
C15H22Cl2N2O4
|
|
PWKRNMKZGWGSDV-UHFFFAOYSA-N
|
1422960-88-0
|
C33H34ClN4+
|
|
(2S)-2-(difluoromethyl)pyrrolidine hydrochloride
|
1423015-69-3
|
C5H10ClF2N
|
|
DDE-ORN(FMOC)-OH
|
1423017-87-1
|
C30H34N2O6
|
|
Ethyl thio-beta-D-galactopyranoside 2,4,6-tribenzoate
|
1423018-01-2
|
C29H28O8S
|
|
(Tert-Butoxy)Carbonyl D-Dap(Boc)-OH·DCHA
|
1423018-02-3
|
C25H47N3O6
|
|
Fmoc-Dap(Octanoyl)-OH
|
1423018-04-5
|
C26H32N2O5
|
|
LY-2922470
|
1423018-12-5
|
C28H29NO4S
|
|
methyl 5-((8-methoxy-3,4-dihydroquinolin-1(2H)-yl)methyl)thiophene-2-carboxylate
|
1423018-14-7
|
C17H19NO3S
|
|
(2,6-Dichloro-phenyl)-Methyl-aMine hydrochloride
|
1423029-60-0
|
C7H8Cl3N
|
|
6-Isopropylnicotinic acid hydrochloride
|
1423029-80-4
|
C9H12ClNO2
|
|
4-AMinoisoquinoline hydrochloride
|
1423031-91-7
|
C9H9ClN2
|
|
2-AMINO-2-(4-(TRIFLUOROMETHYL)PHENYL)ETHANOL HCl
|
1423032-18-1
|
C9H11ClF3NO
|
|
6,6-Difluorospiro[3.3]heptan-2-amine hydrochloride
|
1423032-71-6
|
C7H12ClF2N
|
|
imidazo[1,2-a]pyridine-3-carboxylicacid
|
1423033-64-0
|
C8H6N2O2
|
|
Octyl-β-D-glucuronide methyl ester
|
1423035-40-8
|
C15H28O7
|
|
3-broMo-5-chloro-6-Methylpyridin-2-ol
|
1423037-27-7
|
C6H5BrClNO
|
|
(±)-trans-4-(4-methyl-phenyl)-pyrrolidine-3-carboxylic acidHCl (Rel)
|
1423037-43-7
|
C12H16ClNO2
|
|
(TRANS)-4-(3-BROMO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID-HCL
|
1423037-48-2
|
C11H13BrClNO2
|
|
(4-formyl-1H-[1,2,3]-triazol-1-yl)methyl pivalate
|
1423037-50-6
|
C9H13N3O3
|
|
(R)-7-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride
|
1423040-65-6
|
C11H16ClNO
|
|
Poly[(9,9-dioctylfluorenyl-2,7-diyl)-alt-(6,6'-{2,2'- bipyridine})]
|
1423043-97-3
|
|
|
2-(azetidin-3-yl)acetonitrile hydrochloride
|
1423057-36-6
|
C5H9ClN2
|
|
BRD9757
|
1423058-85-8
|
C6H9NO2
|
|
(3R,4S)-4-p-tolylpyrrolidine-3-carboxylic acid
|
1423117-69-4
|
C12H15NO2
|
|
Dabrafenib-D9
|
1423119-98-5
|
C23H20F3N5O2S2
|
|
5-chloro-6-nitro-1H-indole
|
1423120-30-2
|
C8H5ClN2O2
|
|
6-Chloroindole-5-carbonitrile
|
1423120-66-4
|
C9H5ClN2
|
|
Methyl 3-(Boc-aMino)-3-(3-hydroxyphenyl)propanoate
|
1423134-61-5
|
C15H21NO5
|
|
Fasudil IMpurity 1
|
1423155-03-6
|
C14H17N3O2S
|
|
Ad-BellGiphos-1-Nap
|
1423165-22-3
|
C31H37OP
|
|
RIP2 kinase inhibitor 1
|
1423186-80-4
|
C21H22N4O4S2
|
|
5-iodo-3-methylisothiazole-4-carboxamide
|
1423700-20-2
|
C5H5IN2OS
|
|
1-[4-(4.4.5.5-tetramethyl-[1.3.2]dioxaborolan-2-yl)-biphenyl-4-yl]-cyclopropanecarboxylic acid methyl ester
|
1423700-75-7
|
C23H27BO4
|
|
methyl 1-(6-bromonaphthalen-2-yl)cyclopropane-1-carboxylate
|
1423703-16-5
|
C15H13BrO2
|
|
1-(4-Bromophenyl)-1H-imidazole-5-carboxylic acid
|
1423706-23-3
|
C10H7BrN2O2
|
|
methyl 1-(thieno[3,2-B]thiophen-2-yl)cyclopropane-1-carboxylate
|
1423707-57-6
|
C11H10O2S2
|
|
SP2509
|
1423715-09-6
|
C19H20ClN3O5S
|
|
Seclidemstat
|
1423715-37-0
|
C20H23ClN4O4S
|
|
6,6-Dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid ethyl ester
|
1423716-54-4
|
C12H18N2O2
|
|
(4-Fluorobenzofuran-2-yl)boronic acid
|
1423791-86-9
|
C8H6BFO3
|
|
Apixaban Impurity 17
|
1423803-24-0
|
C20H19N5O3
|
|
7α-Hydroxy-4,11-cadinadiene-3,8-dione
|
1423809-64-6
|
C15H20O3
|
|
2H-Tetrazole, 5-[4-(1H-1,2,4-triazol-1-yl)phenyl]-
|
1423810-54-1
|
C9H7N7
|
|
3-(5-tert-Butyl-isoxazol-3-yl)-3-oxo-propionitrile
|
1423915-00-7
|
C10H12N2O2
|
|
Rucaparib Impurity 6
|
1424059-28-8
|
C19H16FN3O
|
|
1,1,1-Trifluoro-N-[(11aS)-10,11,12,13-tetrahydro-5-oxido-
3,7-bis(2,4,6-trisisopropylphenyl)diindeno[7,1-de:1',7'-fg]
[1,3,2]dioxaphosphocin-5-yl]methanesulfonamide
|
1424201-66-0
|
C48H59F3NO5PS
|
|
SJ-733
|
1424799-20-1
|
C24H16F4N4O2
|
|
Aripiprazole iMpurity 4
|
1424857-63-5
|
C36H42Cl2N4O4
|
|
EsoMeprazole iMpurity
|
1424857-86-2
|
C11H15NO3
|
|
Aripiprazole-Impurity 17
|
1424857-89-5
|
C16H17Cl4N3
|
|
Aripiprazole iMpurity 2
|
1424857-93-1
|
C14H18Cl2N2
|
|
Aripiprazole Related CoMpound B
|
1424858-02-5
|
C26H32N2O5
|
|
4-chloro-3-isobutyl-1-methyl-1H-pyrazolo[3,4-d]pyrimidine
|
1424941-66-1
|
C10H13ClN4
|
|
Rivaroxaban Impurity 93
|
1424944-35-3
|
C22H19N3O6
|
|
(s)-3,3-diMethyl-2-((1r,2r)-2-pent-4-ynyl- CyclopropoxycarbonylaMino)-butyricacid
|
1425038-19-2
|
C15H23NO4
|
|
methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-2-(methoxycarbonyl)pyrrolidinium methanesulfonate
|
1425038-20-5
|
C16H20ClN3O7S
|
|
(S)-3,3-Dimethyl-2-((1R,2R)-2-pent-4-ynyl-cyclopropoxycarbonylamino)-butyric acid, tert-butylamine salt
|
1425038-21-6
|
C19H34N2O4
|
|
methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate
|
1425038-23-8
|
C30H36N4O7
|
|
MK 5172 sodiuM salt
|
1425038-27-2
|
C38H50N6NaO9S+
|
|
IPI3063
|
1425043-73-7
|
C25H25N7O2
|
|
1-Isopropyl-1H-1,2,4-Triazole-3-Carboxylic Acid
|
1425090-56-7
|
C6H9N3O2
|
|
tert-butyl ((1S,3S)-3-hydroxycyclohexyl)carbamate
|
1425253-99-1
|
C11H21NO3
|
|
7-Iodoquinazoline
|
1425310-59-3
|
C8H5IN2
|
|
6-chloro-4-ethynylpyridazin-3-aMine
|
1425334-86-6
|
C6H4ClN3
|
|
1-(tert-butoxycarbonyl)-1H-pyrrolo[2,3-b]pyridin-3-ylboronic acid
|
1425334-89-9
|
C12H15BN2O4
|
|
8-broMo-5-fluoro-2-(trifluoroMethyl)quinoline
|
1425335-26-7
|
C10H4BrF4N
|
|
(S)-tert-butyl 2-cyano-4-oxopiperidine-1-carboxylate
|
1425335-76-7
|
C11H16N2O3
|
|
3-Isopropyl-4-piperidone (hydrochloride)
|
1425366-30-8
|
C8H16ClNO
|
|
Gusacitinib
|
1425381-60-7
|
C24H28N8O2
|
|
DBCO-C6-acid
|
1425485-72-8
|
C21H19NO3
|
|
Methisosildenafil impure
|
1425504-78-4
|
C25H36N6O4S
|
|
2-(2-((5-bromothiophen-2-yl)methylene)-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile
|
1425543-23-2
|
C17H7BrN2OS
|
|
5-Quinolinecarboxylic acid,7-fluoro-2-(4-fluorophenyl)-1,2,3,4-tetrahydro-3-(1-Methyl-1H-1,2,4-triazol-5-yl)-4-oxo-,Methyl ester,(2R,3R)-
|
1425767-92-5
|
C20H16F2N4O3
|
|
Clomipramine HCl EP Impurity G
|
1425793-87-8
|
C17H16ClN
|
|
4-Styryl-1,4-dihydro-benzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-ylamine
|
1425924-54-4
|
C17H15N5
|
|
2(1H)-Quinolinone, 6-amino-1,3-dimethyl-
|
1425927-75-8
|
C11H12N2O
|
|
5-(3,3-Difluoro-cyclobutyl)-2H-pyrazol-3-ylaMine
|
1425931-95-8
|
C7H9F2N3
|
|
5-(2-((4-Methoxybenzyl)oxy)ethyl)-1H-pyrazol-3-aMine
|
1425931-97-0
|
C13H17N3O2
|
|
5-Oxetan-3-yl-1H-pyrazol-3-ylaMine
|
1425932-06-4
|
C6H9N3O
|
|
(4-Methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-benzo[d]iMidazol-5-yl)MethanaMine
|
1425933-32-9
|
C14H19N3O
|
|
lithiuM 1-(pyridin-2-yl)-2,6,7-trioxa-1-borabicyclo[2.2.2]octan-1-uide
|
1425937-24-1
|
C9H11BLiNO3
|